Search

Your search keyword '"Adam Ioannou"' showing total 90 results

Search Constraints

Start Over You searched for: Author "Adam Ioannou" Remove constraint Author: "Adam Ioannou"
90 results on '"Adam Ioannou"'

Search Results

1. Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis

2. Cardiovascular Magnetic Resonance (CMR) in Transthyretin Amyloid Cardiomyopathy – a Study of Natural History of Treatment Response

Catalog

Books, media, physical & digital resources

3. Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience

4. Anticoagulation for the prevention of stroke in non-valvular AF in general practice: room for improvement

5. Ventricular Fibrillation following Varicella Zoster Myocarditis

6. Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis

7. Takotsubo cardiomyopathy associated with dydrogesterone use

9. Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis

10. Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment

11. Conventional heart failure therapy in cardiac ATTR amyloidosis

12. Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping

15. Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis

17. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) nosocomial transmission dynamics, a retrospective cohort study of two healthcare-associated coronavirus disease 2019 (COVID-19) clusters in a district hospital in England during March and April 2020

18. 189 PREVALENCE, DISEASE CHARACTERISTICS AND OUTCOMES OF HEREDITARY TRANSTHYRETIN AMYLOID CARDIOMYOPATHY AMONG ELDERLY INDIVIDUALS

19. Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years

20. Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis

23. A standardised pathway increases clinicians’ confidence and ability to manage implantable cardioverter defibrillator shocks

24. Drug-related bradycardia precipitating hospital admission in older adults: an ongoing problem

26. Imaging-Guided Treatment for Cardiac Amyloidosis

27. Pulmonary embolism in COVID-19: Clinical characteristics and cardiac implications

28. Antithrombotic Therapy in Patients with Recent Stroke and Atrial Fibrillation

29. Comparison of the Effect of Sacubitril/Valsartan on Left Ventricular Systolic Function in Patients with Non-ischaemic and Ischaemic Cardiomyopathy

30. Long term use of donepezil and QTc prolongation

31. Iatrogenic adrenaline induced mid-ventricular Takotsubo cardiomyopathy: a case-based review

32. Coronary artery bypass surgery versus medical therapy alone for ischaemic heart disease

35. Delayed olanzapine induced myocarditis and rhabdomyolysis

37. Audit of the prevalence and investigation of iron deficiency anaemia in patients with heart failure in hospital practice

38. Inflammatory Biomarkers in Atrial Fibrillation

39. In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis

40. Atrial Fibrillation is A Predictor of Drug-Related Bradycardia and Hospital Admission in Older Adults

41. Donepezil induces ventricular arrhythmias by delayed repolarisation

42. Letter to the Editor - New Pharmacotherapy for Heart Failure with Reduced Ejection Fraction

43. Response to: Fundamental issues in the diuretic lounge strategy

44. Efficacy and safety of ablation index-guided catheter ablation for atrial fibrillation: an updated meta-analysis

45. Diuretic lounge and the impact on hospital admissions for treatment of decompensated heart failure

46. Registry report of the prevalence of ECG abnormalities and their relation to patient characteristics in an asymptomatic population

49. Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination

50. Non-valvular atrial fibrillation: impact of apixaban on patient outcomes